Shandong Boan Biotechnology Co., Ltd.

Research Shandong Boan Biotechnology Co., Ltd. (6955.HK) on Bullrun: market cap HKD 1.86B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker6955.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryBiotechnology
CurrencyHKD
Market capHKD 1.86B
Financial periodFY2025
RevenueCNY 784.82M
Revenue growth8.1%
Net incomeCNY 7.14M
Free cash flow-CNY 209.16M
Gross margin71.7%

Valuation Snapshot

latest market cap is HKD 1.86B.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 784.82M	CNY 7.14M	-CNY 209.16M	71.7%	0.01	CNY 1.13B	CNY 783.28M	CNY 2.74B
FY2024	CNY 726.32M	CNY 73.19M	-CNY 480.84M	74.7%	0.14	CNY 198.87M	CNY 685.54M	CNY 1.64B
FY2023	CNY 618.13M	-CNY 119.38M	-CNY 313.33M	66.2%	-0.23	CNY 201.85M	CNY 405.91M	CNY 1.32B
FY2022	CNY 515.96M	-CNY 331.75M	-CNY 408.22M	68.7%	-0.67	CNY 233.50M	CNY 301.72M	CNY 1.42B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 1.86B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Shandong Boan Biotechnology Co., Ltd.

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Hualan Biological Engineering INC (002007.SZ) Shanghai RAAS Blood Products Co Ltd (002252.SZ) Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) CANbridge Pharmaceuticals Inc. (1228.HK) 3D Medicines Inc. (1244.HK) Ocumension Therapeutics (1477.HK) 3SBio Inc. (1530.HK) LongBio Pharma (Suzhou) Co., Ltd. (1779.HK) Innovent Biologics, Inc. (1801.HK) Viva Biotech Holdings (1873.HK) BioDlink International Company Limited (1875.HK)

Frequently asked questions

What is Shandong Boan Biotechnology Co., Ltd.'s market cap?

Shandong Boan Biotechnology Co., Ltd.'s market capitalization is HKD 1.86B.

What does Shandong Boan Biotechnology Co., Ltd. do?

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.